Safety note: Admin approval is an initial review, not a guarantee that every detail is correct. Check important or urgent claims with official sources and report anything inaccurate or unsafe.
Source and credit: Contributor's own report
Ceretas Moves Headquarters to Brisbane’s Edward Street - Brisbane, QLD
Smart summary
Medical technology company Ceretas has relocated its registered office and principal place of business to Brisbane’s Edward Street.
Medical technology company Ceretas Limited has announced the immediate relocation of its registered office and principal place of business to Edward Street in Brisbane’s CBD.
The company has moved its registered office to Level 4, 348 Edward Street, Brisbane, Queensland, with the change taking effect on 14 August 2026. The announcement was made as part of a formal company update.
Ceretas is a clinical-stage medical technology company developing a portable, non-invasive therapeutic ultrasound platform. Its technology is being developed for potential applications involving Alzheimer's disease and other neurological conditions.
The company says its technology is based on research developed through more than a decade of work involving researchers at The University of Queensland and the Queensland Brain Institute.
The platform uses low-intensity focused ultrasound delivered through the skull. The technology is being investigated for its potential effects on brain activity and for opening the blood-brain barrier, which could potentially support future therapeutic approaches.
Research associated with the technology has already progressed into human clinical studies. A first-in-human Phase 1 study involving Alzheimer's patients was completed in 2024, with research findings subsequently published.
Ceretas is now preparing for further clinical development, including a planned Phase 2 study focused on Alzheimer's patients experiencing behavioural and psychological symptoms associated with dementia.
The company has also highlighted another Phase 2 study being independently funded through Queensland Health.
The relocation to Brisbane's CBD places the company's registered office closer to Queensland's growing medical research and technology ecosystem. Brisbane has a strong connection to biomedical research through universities, hospitals, research institutions and technology companies.
The move also reflects the company's continuing development as it progresses its therapeutic ultrasound platform toward further clinical testing.
For Brisbane, the announcement adds another medical-technology company to the city's growing technology and research community. The city's universities and research institutions have increasingly contributed to developments in biotechnology, medical devices and healthcare innovation.
The company has confirmed that its other contact information remains unchanged following the relocation.
CompanyTechnologyResearchBrisbaneQueensland
Medical technology company Ceretas Limited has announced the immediate relocation of its registered office and principal place of business to Edward Street in Brisbane’s CBD.
The company has moved its registered office to Level 4, 348 Edward Street, Brisbane, Queensland, with the change taking effect on 14 August 2026. The announcement was made as part of a formal company update.
Ceretas is a clinical-stage medical technology company developing a portable, non-invasive therapeutic ultrasound platform. Its technology is being developed for potential applications involving Alzheimer's disease and other neurological conditions.
The company says its technology is based on research developed through more than a decade of work involving researchers at The University of Queensland and the Queensland Brain Institute.
The platform uses low-intensity focused ultrasound delivered through the skull. The technology is being investigated for its potential effects on brain activity and for opening the blood-brain barrier, which could potentially support future therapeutic approaches.
Research associated with the technology has already progressed into human clinical studies. A first-in-human Phase 1 study involving Alzheimer's patients was completed in 2024, with research findings subsequently published.
Ceretas is now preparing for further clinical development, including a planned Phase 2 study focused on Alzheimer's patients experiencing behavioural and psychological symptoms associated with dementia.
The company has also highlighted another Phase 2 study being independently funded through Queensland Health.
The relocation to Brisbane's CBD places the company's registered office closer to Queensland's growing medical research and technology ecosystem. Brisbane has a strong connection to biomedical research through universities, hospitals, research institutions and technology companies.
The move also reflects the company's continuing development as it progresses its therapeutic ultrasound platform toward further clinical testing.
For Brisbane, the announcement adds another medical-technology company to the city's growing technology and research community. The city's universities and research institutions have increasingly contributed to developments in biotechnology, medical devices and healthcare innovation.
The company has confirmed that its other contact information remains unchanged following the relocation.
Perth Western Australia · Technology News · 03 Sep 2026
Western Australia Police have announced that hundreds of fines issued through AI-assisted traffic cameras are being dropped following a review of the technology and enforcement...
The state government has launched a bid to host the United Nations climate conference, highlighting Whyalla’s major renewable-energy and hydrogen develo...
A Perth office has introduced a new mobile video-conferencing system to improve communication between Western Australian staff, remote facilities and in...
A temporary Mastercard outage disrupted tap-and-go and digital-wallet payments across Australia before the card provider confirmed services had been res...
Two more men have been identified in court as police investigations continue into an alleged cocaine distribution network operating through local pubs.
Police are investigating an alleged hit-and-run in which a 45-year-old man was struck and dragged by a stolen van before the vehicle was reportedly invo...
Police have raided the CFMEU's Bowen Hills headquarters as part of a Queensland-Victoria investigation into alleged corrupting benefits linked to union...
Flight delays and cancellations affected Sydney Airport passengers on Friday morning after staffing shortages prompted temporary air-traffic management...
